Abstract
Thymic output and homeostatic mature cell proliferation both influence T cell repopulation following depletional induction, though the relative contribution of each and their association with recipient age have not been well studied. We investigated the repopulating T cell kinetics in kidney transplant recipients who underwent alemtuzumab induction followed by belatacept/rapamycin-based immunosuppression over 36-month posttransplantation. We focused specifically on the correlation between repopulating T cell subsets and the age of patients. Substantial homeostatic Ki67-expressing T cell proliferation was seen posttransplantation. A repertoire enriched for naïve T (TNaïve) cells emerged posttransplantation. Analysis by generalized estimating equation linear models revealed a strong negative linear association between reconstituting TNaïve cells and advancing age. A relationship between age and persistence of effector memory cells was shown. We assessed thymic output and found an increase in the frequency of recent thymic emigrants (RTEs, CD4+CD31+) at 12-month posttransplantation. Patients under 30 years of age showed significantly higher levels of CD4+CD31+ cells than patients over 55 years of age pre- and posttransplantation. IL-7 and autologous mature dendritic cells (mDCs) induced CD57− cell proliferation. In contrast, mDCs, but not IL-7, induced CD57+ cell proliferation. This study establishes the relationship between age and thymic output during T cell homeostatic repopulation after alemtuzumab induction. Trial Registration: ClinicalTrials.gov - NCT00565773.
Original language | English |
---|---|
Pages (from-to) | 3163-3174 |
Number of pages | 12 |
Journal | American Journal of Transplantation |
Volume | 21 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2021 |
Externally published | Yes |
Keywords
- basic (laboratory) research/science
- clinical research/practice
- immunobiology
- immunosuppressant - fusion proteins and monoclonal antibodies: alemtuzumab
- immunosuppressant - fusion proteins and monoclonal antibodies: belatacept
- immunosuppression/immune modulation
- immunosuppressive regimens - induction
- kidney transplantation/nephrology
- lymphocyte biology: differentiation/maturation
- lymphocyte biology: proliferation